|
Market Cap (17-May) $40,671,720 (1,053rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 400,697 |
Shortsold (10-Dec) 1,128,575 (0.62%) (255th) |
|
52w High $0.345 |
52w Low $0.140 |
P/E - |
EPS -0.05 |
CYP released this announcement to the ASX on 17 October 2022, 9:28. The announcement is marked as price sensitive, and is 2 page(s) in length and 249.47kb in size.
You can view all announcements from CYP and see how they appear on a price chart on the announcements page.
At the date of this announcement, CYP was 0.003% short sold according to ASIC data. It was ranked the 613th most shorted stock on the ASX. It is now ranked as the 255th most shorted stock on the ASX with 0.624% of total shares short sold as of the latest reported data (10 December 2024).
| Other Recent Announcements from CYP | |
|---|---|
| Notification regarding unquoted securities - CYP | 30 June 2023, 13:10 |
| Proposed issue of securities - CYP | 30 June 2023, 9:44 |
| Cynata announces CEO succession and Board changes | 30 June 2023, 9:13 |
| Notice of Allowance for Australia & Canada Cymerus Patents | 17 October 2022, 9:28 |
| Successful Completion of Planned DSMB Review of DFU Trial | 12 October 2022, 9:26 |
| Date of AGM and Closing Date for Director Nominations | 27 September 2022, 8:51 |
| Grant Award to Fund Study of Cynata MSCs in Heart Disease | 26 September 2022, 9:07 |
You must be logged in to post a reply.
Cynata Therapeutics 